In silico studies to identify potential natural antiviral agents to treat and control SARS-CoV-2 (COVID-19). (Special Issue: Covid-19 in India.)

ABSTRACT

Background: Recently, a new and fatal strain of coronavirus named as SARS-CoV-2 (Disease COVID-19) appeared in Wuhan, China in December of 2019 and was officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses based on phylogenetic analysis. Because of its highly contagious nature, there is an urgent need for suitable drug which can control the viral infection. The covid 19 main protease was found to be the best target for drug synthesis as it involved in viral replication.